超声引导下经皮粗针活检诊断1型自身免疫性胰腺炎
研究纳入2017年1月至2023年6月病理含「淋巴浆细胞浸润」和「纤维化」的患者61例,其中56例最终诊断为1型自身免疫性胰腺炎;加用超声引导下粗针活检病理评估后,明确诊断率由44.3%提高至67.2%(p=0.017),联合诊断性激素试验后达91.8%(p=0.001);12个月随访时48例反应良好。
要点
- 超声引导下粗针活检可使1型自身免疫性胰腺炎明确诊断率从44.3%提高至67.2%。
- 26例(46.4%,26/56)通过超声引导下粗针活检病理达到ICDC 1级组织学标准。
- 加用诊断性激素试验后明确诊断率进一步提高至91.8%。
核心结论
- 超声引导下粗针活检是诊断1型自身免疫性胰腺炎的有效方法,将其加入诊断流程可获得较高的缓解率。
研究设计与样本
- 单中心研究,纳入2017年1月至2023年6月病理结果含「淋巴浆细胞浸润」和「纤维化」的患者61例,其中56例最终诊断为1型自身免疫性胰腺炎;采用国际共识诊断标准(ICDC)评估1级组织学检出率及超声引导下粗针活检的贡献,并评估活检后激素治疗的影像学反应。
诊断标准与关键数值
- 按ICDC标准,56例中26例(46.4%,26/56)通过超声引导下粗针活检达到1级组织学标准;61例中27例(44.3%)无组织学证据即诊断为明确1型自身免疫性胰腺炎,加用超声引导下粗针活检病理评估后明确诊断率提高至67.2%(44.3% vs. 67.2%,p=0.017)。
临床应用与阅片要点
- 对病理含「淋巴浆细胞浸润」和「纤维化」的患者,超声引导下粗针活检可提高1型自身免疫性胰腺炎的明确诊断率;其余20例未确诊患者中13例(21.3%)经诊断性激素试验最终诊断为明确1型自身免疫性胰腺炎、2例(3.3%)为可能1型自身免疫性胰腺炎,联合后明确诊断率达91.8%(67.2% vs. 91.8%,p=0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study aimed to investigate the usefulness of ultrasound-guided core-needle biopsy (US-CNB) for diagnosing type 1 AIP and evaluate the radiological outcomes following steroid therapy.
MATERIALS AND METHODS: From January 2017 to June 2023, patients with pathology results containing "lymphoplasmacytic infiltration" and "fibrosis" were enrolled. The detection rate of level 1 histology by International Consensus Diagnostic Criteria (ICDC) and the contribution of US-CNB were assessed. The radiological responses to steroid therapy following biopsy were assessed and classified.
RESULTS: Sixty-one patients were included, 56 of whom ended up with a diagnosis of type 1 AIP. Twenty-six (46.4%, 26/56) patients met the level 1 criteria of type 1 AIP. Of the 61 enrolled patients, 27 (44.3%) were diagnosed with definitive type 1 AIP without evidence from histology. The addition of pathologic evaluation of the pancreas tissue collected by US-CNB improved the diagnostic rate of definitive type 1 AIP to 67.2% (44.3% vs. 67.2%, p = 0.017). Among the remaining 20 undiagnosed patients, 13 (21.3%) finally were diagnosed with definitive type 1 AIP, and 2 (3.3%) with probable type 1 AIP by a diagnostic steroid trial (67.2% vs. 91.8%, p = 0.001). At the 12-month follow-up, a favorable response was observed in 48 patients, a partial response in 5 patients, relapse in 1 patient and disease progression in 2 patients.
CONCLUSION: US-CNB is an effective diagnostic method for type 1 AIP. A high remission rate of AIP was achieved with the addition of US-CNB to the diagnostic algorithm.
引用
- Zhao Q, Chai W, Jin X, et al. Ultrasound-guided percutaneous core-needle biopsy for the diagnosis of type 1 autoimmune pancreatitis. Abdom Radiol (NY). 2025. PMID: 39745529. doi:10.1007/s00261-024-04780-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。